0719.HK

Shandong Xinhua Pharmaceutical Company Limited [0719.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0719.HK Stock Summary

Top 10 Correlated Stocks

0719.HK


In the News

0719.HK Financial details

Company Rating
Strong Buy
Market Cap
10B
Income
509.72M
Revenue
8.55B
Book val./share
6.6
Cash/share
1.14
Dividend
0.22
Dividend %
3.94%
Employees
6.84K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
6.81
Forward P/E
-
PEG
1.82
P/S
1.21
P/B
0.77
P/C
4.72
P/FCF
37.1
Quick Ratio
0.89
Current Ratio
1.38
Debt / Equity
0.3
LT Debt / Equity
0.17
-
-
EPS (TTM)
0.77
EPS next Y
-
EPS next Q
-
EPS this Y
10.71%
EPS next Y
-
EPS next 5Y
-20.27%
EPS last 5Y
9.16%
Revenue last 5Y
7.58%
Revenue Q/Q
-10.2%
EPS Q/Q
-
-
-
-
-
SMA20
-16.67%
SMA50
-16.67%
SMA100
-16.67%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.1%
Gross Margin
29%
Oper. Margin
7%
Profit Margin
6%
Payout
37%
Shs Outstand
1.86B
Shs Float
1.86B
-
-
-
-
Target Price
-
52W Range
4.8-7.47
52W High
-23.14%
52W Low
+34.5%
RSI
40
Rel Volume
0.56
Avg Volume
1.15M
Volume
651.6K
Perf Week
-2.89%
Perf Month
-0.19%
Perf Quarter
5.7%
Perf Half Y
-3.76%
-
-
-
-
Beta
-0.011
-
-
Volatility
0.1%, 0.1%
Prev Close
1.7%
Price
5.38
Change
1.51%

0719.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
8.368.979.6110.5411.13
Net income per share
0.40.480.520.560.61
Operating cash flow per share
0.550.560.670.421.12
Free cash flow per share
-0.07-0.030.220.020.76
Cash per share
1.141.11.271.111.72
Book value per share
4.324.755.165.576.12
Tangible book value per share
3.964.324.715.125.75
Share holders equity per share
4.324.755.165.576.12
Interest debt per share
2.282.461.841.762.13
Market cap
1.99B2.13B1.87B2.36B4.85B
Enterprise value
2.57B2.92B2.1B2.66B5.08B
P/E ratio
7.937.115.746.7811.8
Price to sales ratio
0.380.380.310.360.65
POCF ratio
5.776.124.449.126.4
PFCF ratio
-48.07-116.8613.33238.849.45
P/B Ratio
0.740.720.580.681.18
PTB ratio
0.740.720.580.681.18
EV to sales
0.490.520.350.410.68
Enterprise value over EBITDA
3.513.392.332.844.84
EV to operating cash flow
7.478.394.9910.276.7
EV to free cash flow
-62.23-160.1214.99269.089.89
Earnings yield
0.130.140.170.150.08
Free cash flow yield
-0.02-0.010.0800.11
Debt to equity
0.510.50.340.30.34
Debt to assets
0.230.230.150.140.17
Net debt to EBITDA
0.80.920.260.320.21
Current ratio
10.981.131.11.09
Interest coverage
6.1877.078.019.59
Income quality
1.261.081.210.721.78
Dividend Yield
0.050.050.070.060.03
Payout ratio
0.360.390.390.430.4
Sales general and administrative to revenue
0.020.020.020.020.02
Research and developement to revenue
0.040.040.050.050.05
Intangibles to total assets
0.060.060.060.060.06
Capex to operating cash flow
-1.12-1.05-0.67-0.96-0.32
Capex to revenue
-0.07-0.07-0.05-0.04-0.03
Capex to depreciation
-1.28-1.06-0.73-0.57-0.5
Stock based compensation to revenue
00000.01
Graham number
6.257.167.778.389.17
ROIC
0.070.070.080.080.08
Return on tangible assets
0.040.050.050.050.05
Graham Net
-2.45-2.71-3.04-2.85-2.04
Working capital
-10.88M-57.13M305.83M252.08M298.47M
Tangible asset value
2.46B2.7B2.94B3.18B3.88B
Net current asset value
-770.44M-897.11M-1.01B-926.93M-458.27M
Invested capital
0.510.50.340.30.34
Average receivables
524.51M525M548.68M764.92M986.3M
Average payables
813.95M844.06M770.71M904.65M1.08B
Average inventory
832.47M1.04B1.13B1.08B1.12B
Days sales outstanding
38.2232.8636.0252.1450.37
Days payables outstanding
88.9778.1164.781.3272.8
Days of inventory on hand
95.18110.5797.9278.3680.94
Receivables turnover
9.5511.1110.1377.25
Payables turnover
4.14.675.644.495.01
Inventory turnover
3.833.33.734.664.51
ROE
0.090.10.10.10.1
Capex per share
-0.62-0.59-0.45-0.4-0.36

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.83.043.832.952.69
Net income per share
0.160.170.220.170.18
Operating cash flow per share
0.160.170.220.30.08
Free cash flow per share
0.040.10.140.2-0.04
Cash per share
1.91.721.251.361.14
Book value per share
6.226.126.276.286.6
Tangible book value per share
5.835.755.925.936.24
Share holders equity per share
6.226.126.276.286.6
Interest debt per share
2.962.071.961.952.01
Market cap
2.22B4.85B3.71B3.78B3.46B
Enterprise value
2.88B5.08B4.18B4.13B3.99B
P/E ratio
5.5910.36.117.997.08
Price to sales ratio
1.242.371.41.861.9
POCF ratio
22.3741.224.4418.5261.66
PFCF ratio
95.4372.6238.9126.91-140.76
P/B Ratio
0.561.180.860.870.77
PTB ratio
0.561.180.860.870.77
EV to sales
1.612.481.582.032.19
Enterprise value over EBITDA
25.6131.0521.320.2834.02
EV to operating cash flow
29.0643.1127.5620.2771.14
EV to free cash flow
123.9775.9943.8829.44-162.4
Earnings yield
0.040.020.040.030.04
Free cash flow yield
0.010.010.030.04-0.01
Debt to equity
0.470.340.310.310.3
Debt to assets
0.230.170.170.170.17
Net debt to EBITDA
5.891.382.411.754.53
Current ratio
1.081.091.471.31.38
Interest coverage
7.9110.9615.7415.311.05
Income quality
1111.720.46
Dividend Yield
0.050000.04
Payout ratio
1.090.190.080.081.18
Sales general and administrative to revenue
0.13-0.070.05-0.020.15
Research and developement to revenue
0.050.040.040.060.06
Intangibles to total assets
0.060.060.060.060.06
Capex to operating cash flow
-0.77-0.43-0.37-0.31-1.44
Capex to revenue
-0.04-0.02-0.02-0.03-0.04
Capex to depreciation
0.32-0.10-0.250.32
Stock based compensation to revenue
-0.010.0200.01-0.01
Graham number
4.664.915.574.925.17
ROIC
0.020.020.030.020.02
Return on tangible assets
0.010.020.020.020.02
Graham Net
-2.14-2.04-1.63-1.71-1.6
Working capital
242.62M298.47M999.42M752.97M840.68M
Tangible asset value
3.72B3.88B4.08B4.09B4.24B
Net current asset value
-536.86M-458.27M-290.71M-290.22M-194.49M
Invested capital
0.470.340.310.310.3
Average receivables
1.18B1.14B1.15B1.24B1.18B
Average payables
1.21B1.16B1.09B1.12B1.06B
Average inventory
1B1.09B1.09B990.13M990.78M
Days sales outstanding
62.8745.4743.3653.4157.32
Days payables outstanding
83.0568.5353.9770.4465.82
Days of inventory on hand
66.0276.248.1761.965.87
Receivables turnover
1.431.982.081.691.57
Payables turnover
1.081.311.671.281.37
Inventory turnover
1.361.181.871.451.37
ROE
0.020.030.040.030.03
Capex per share
-0.12-0.08-0.08-0.09-0.12

0719.HK Frequently Asked Questions

What is Shandong Xinhua Pharmaceutical Company Limited stock symbol ?

Shandong Xinhua Pharmaceutical Company Limited is a CN stock and trading under the symbol 0719.HK

What is Shandong Xinhua Pharmaceutical Company Limited stock quote today ?

Shandong Xinhua Pharmaceutical Company Limited stock price is $5.38 today.

Is Shandong Xinhua Pharmaceutical Company Limited stock public?

Yes, Shandong Xinhua Pharmaceutical Company Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap